Outcome of Steroid Therapy for Myocardial Inflammation in Scleroderma
Status:
Completed
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
Primary myocardial involvement is common in scleroderma, effected to pericardium, vascular,
conducting defect and especially myocardium. Cardiac MRI is widely used for assessment of
cardiac involvement in scleroderma, both structural and functional pathology. Cardiac MRI has
a diagnostic accuracy of 85% for the detection of myocardial inflammation. Nowadays, the
treatment of myocardial inflammation in scleroderma is uncertain. The investigator's study
aims to define the cardiac outcome after moderate dose steroid therapy in the patients who
have myocardial inflammation detection by cardiac MRI.